SFTPB and lung carcinoma: Over the past l0 years, a significant amount of research data has accumulated on other promising biomarkers for lung cancer detection: autoimmune antibody signature (Autoantibody signature, AAB) (31), micro-RNA (32) and pro-surfactant Protein B (Pro-SFTPB) (33).